2021-01-11,Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Corporate Milestones
2021-01-05,Deciphera Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
2020-12-20,DCPH Stock Forecast: Where Do Hedge Funds Stand?
2020-12-18,"The Zacks Analyst Blog Highlights: BioMarin Pharmaceutical, uniQure, REGENXBIO and Deciphera Pharmaceuticals"
2020-12-01,Deciphera (DCPH) Ends Qinlock Second-Line GIST Study Enrollment
2020-11-30,Deciphera Pharmaceuticals Completes Target Enrollment in the INTRIGUE Phase 3 Clinical Study of QINLOCK® (Ripretinib) in Patients with Second-Line Gastrointestinal Stromal Tumor
2020-11-24,"Deciphera Pharmaceuticals, Inc. to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference"
2020-11-23,The Boston Globe Names Deciphera a Top Place to Work for 2020
2020-11-11,Deciphera Presents Data from QINLOCK® (Ripretinib) Program at the Connective Tissue Oncology Society (CTOS) 2020 Virtual Annual Meeting
2020-11-11,"Deciphera Presents Updated Preliminary Data from DCC-3014, its CSF1R Inhibitor Program, in Tenosynovial Giant Cell Tumor Patients at the Connective Tissue Oncology Society (CTOS) 2020 Virtual Annual Meeting"
2020-11-10,"Deciphera Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference"
2020-11-10,"News Flash: Analysts Just Made A Sizeable Upgrade To Their Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Forecasts"
2020-11-09,Deciphera (DCPH) Reports Narrower-Than-Expected Loss in Q3
2020-11-06,"Deciphera Pharmaceuticals, Inc. (DCPH) Q3 2020 Earnings Call Transcript"
2020-11-05,"Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2020 Financial Results"
2020-11-05,"Deciphera Pharmaceuticals, Inc. to Host Earnings Call"
2020-10-28,"Deciphera Pharmaceuticals, Inc. to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 5, 2020"
2020-09-22,Blueprint Medicines Reports Positive Test Results For Rare Disease Treatment; BPMC Stock Jumps
2020-09-20,"An Intrinsic Calculation For Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Suggests It's 48% Undervalued"
2020-09-18,Deciphera Presents Data from QINLOCK (Ripretinib) Program in Patients with Gastrointestinal Stromal Tumor at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
2020-09-17,"Deciphera Presents Data from Rebastinib, its TIE2 Inhibitor Program, at the European Society for Medical Oncology (ESMO) Virtual Congress 2020"
2020-09-15,"Hedge Funds Never Been This Bullish On Deciphera Pharmaceuticals, Inc. (DCPH)"
2020-08-17,Deciphera Announces Publication of QINLOCK (ripretinib) Phase 1 Study Results in Patients with Gastrointestinal Stromal Tumor in Journal of Clinical Oncology
2020-08-06,"Deciphera Pharmaceuticals, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference"
2020-08-05,"Deciphera Pharmaceuticals, Inc. (DCPH) Q2 2020 Earnings Call Transcript"
2020-08-04,"Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q2 Loss, Tops Revenue Estimates"
2020-08-04,"Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2020 Financial Results"
2020-07-29,"Deciphera Pharmaceuticals, Inc. to Announce Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 4, 2020"
2020-07-20,China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor
2020-07-20,China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor
2020-07-14,Deciphera Announces Australian Therapeutic Goods Administrations Approval of QINLOCK (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
2020-07-12,"Did Hedge Funds Make The Right Call On Deciphera Pharmaceuticals, Inc. (DCPH) ?"
2020-07-09,"Industry Analysts Just Upgraded Their Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Revenue Forecasts By 12%"
2020-07-02,Deciphera Announces Presentation of Analysis of Crossover Population from the INVICTUS Phase 3 Study of QINLOCK (ripretinib) in Patients with Fourth-Line Advanced GIST
2020-06-22,Deciphera Announces Health Canadas Authorization of QINLOCK (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
2020-06-17,3 Strong Buy Healthcare Stocks That Should Remain Healthy
2020-06-11,Deciphera Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Forum
2020-06-08,Deciphera Announces Publication of the INVICTUS Pivotal Phase 3 Study of QINLOCK (ripretinib) in The Lancet Oncology
2020-06-08,"Hedge Funds Have Never Been More Bullish On Deciphera Pharmaceuticals, Inc. (DCPH)"
2020-06-03,The Debate Is Over: This Cancer Stock Is Winning the GIST Race
2020-05-29,Deciphera Pharmaceuticals Presents Preliminary Data from Phase 1b/2 Study of Rebastinib in Combination with Paclitaxel in Patients with Advanced Endometrial Cancer at the ASCO 2020 Virtual Scientific Program
2020-05-29,Deciphera Pharmaceuticals Announces Presentations of Positive Patient Reported Outcomes Results from INVICTUS Phase 3 Study of QINLOCKTM (ripretinib) in Patients with Fourth-Line Advanced GIST at the ASCO 2020 Virtual Scientific Program
2020-05-27,Deciphera Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference
2020-05-26,"News Flash: Analysts Just Made A Captivating Upgrade To Their Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Forecasts"
2020-05-23,FDA Approval Could Be a Game-Changer for Deciphera Pharmaceuticals
2020-05-18,Deciphera Pharmaceuticals Just Surged Higher On A Rapid Approval
2020-05-18,Deciphera (DCPH) Secures Early FDA Nod for GIST Drug Qinlock
2020-05-18,Nomura Sticks to Their Hold Rating for Deciphera Pharmaceuticals
2020-05-15,FDA Grants Full Approval of Deciphera Pharmaceuticals QINLOCK (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
2020-05-12,"Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Analysts Just Trimmed Their Revenue Forecasts By 14%"
2020-05-08,"Earnings Update: Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Just Reported And Analysts Are Trimming Their Forecasts"
2020-05-06,"Deciphera Pharmaceuticals, Inc. (DCPH) Q1 2020 Earnings Call Transcript"
2020-05-05,"Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates"
2020-05-05,"Deciphera Pharmaceuticals, Inc. Announces First Quarter 2020 Financial Results"
2020-05-04,Eaton Vance Worldwide Health Sciences Fund Adds 3 Stocks to Portfolio
2020-05-04,Is a Surprise Coming for Deciphera (DCPH) This Earnings Season?
2020-04-28,Blueprint Medicines Tumbles 20.8% on Phase 3 Study Failure
2020-04-28,"Deciphera Pharmaceuticals, Inc. to Announce First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 5, 2020"
2020-04-23,Is Deciphera Pharmaceuticals (DCPH) Stock a Solid Choice Right Now?
2020-03-28,"Hedge Funds Have Never Been This Bullish On Deciphera Pharmaceuticals, Inc. (DCPH)"
2020-03-09,"Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q4 Loss, Misses Revenue Estimates"
2020-03-09,"Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2019 Financial Results"
2020-03-09,"Deciphera Pharmaceuticals, Inc. to Host Earnings Call"
2020-03-02,"Deciphera Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call and Webcast on March 9, 2020"
2020-02-20,"Deciphera Pharmaceuticals, Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference"
2020-02-19,Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock
2020-02-13,Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
2020-02-13,Revamped postal center in Waltham will sell for $320M
2020-02-13,Deciphera's NDA for GIST Drug Gets Priority Review From FDA
2020-02-13,"The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO"
2020-02-12,Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock
2020-02-12,Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance of New Drug Application and Priority Review for Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors
2020-01-13,Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2020 Milestones
2020-01-11,"How Did Deciphera Pharmaceuticals, Inc. (DCPH) Compare Against Top Hedge Fund Stocks in 2019?"
2020-01-06,Deciphera Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference
2020-01-02,"Does Market Volatility Impact Deciphera Pharmaceuticals, Inc.'s (NASDAQ:DCPH) Share Price?"
2019-12-17,"The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO"
2019-12-16,Deciphera Pharmaceuticals Announces Submission of New Drug Application to U.S. FDA for Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors
2019-12-05,"Hedge Funds Have Never Been This Bullish On Deciphera Pharmaceuticals, Inc. (DCPH)"
2019-12-04,Deciphera Pharmaceuticals Announces Appointment of Ron Squarer to its Board of Directors
2019-11-26,Deciphera Pharmaceuticals Expands its Board of Directors with Appointment of Frank S. Friedman
2019-11-26,Deciphera Pharmaceuticals Expands its Board of Directors with Appointment of Frank S. Friedman
2019-11-22,"Callon, Fitbit, Genco Shipping and Other 13D Filings"
2019-11-13,"Deciphera Pharmaceuticals, Inc. to Present Data from DCC-3014 and Ripretinib Programs at the Connective Tissue Oncology Society (CTOS) 2019 Annual Meeting"
2019-11-13,"Deciphera Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences"
2019-11-04,"Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q3 Loss, Misses Revenue Estimates"
2019-11-04,"Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2019 Financial Results"
2019-11-01,3 Strong Buy Stocks Jefferies Thinks Are Set to Rip Higher
2019-10-30,What's in Store for GW Pharmaceuticals (GWPH) in Q3 Earnings?
2019-10-29,Deciphera Pharmaceuticals Presents Updated Data from Ripretinib and DCC-3014 Programs at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
2019-10-29,"The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study"
2019-10-28,"Did Hedge Funds Drop The Ball On Deciphera Pharmaceuticals, Inc. (DCPH) ?"
2019-10-28,Deciphera Pharmaceuticals Presents Data from Rebastinib and DCC-3116 Programs at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
2019-10-28,"Deciphera Pharmaceuticals, Inc. to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 4, 2019"
2019-10-17,Can Sequencing Products Drive Illumina's (ILMN) Q3 Earnings?
2019-10-16,Deciphera Pharmaceuticals to Present Data Updates From Portfolio of Kinase Switch Control Inhibitors in Four Poster Sessions at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
2019-10-15,Robotics company Boston Dynamics selects new Waltham HQ
2019-10-04,"Deciphera Pharmaceuticals, Inc. (DCPH) Moves to Buy: Rationale Behind the Upgrade"
2019-10-04,Should Deciphera Pharmaceuticals (NASDAQ:DCPH) Be Disappointed With Their 14% Profit?
2019-10-02,"Deciphera Pharmaceuticals Appoints Matthew L. Sherman, M.D. as Executive Vice President and Chief Medical Officer"
